Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial

OBJECTIVE: To examine whether treatment with epigallocatechin gallate (EGCG) influences progression of brain atrophy, reduces clinical and further radiologic disease activity markers, and is safe in patients with progressive multiple sclerosis (PMS). METHODS: We enrolled 61 patients with primary or...

Descripción completa

Detalles Bibliográficos
Autores principales: Rust, Rebekka, Chien, Claudia, Scheel, Michael, Brandt, Alexander U., Dörr, Jan, Wuerfel, Jens, Klumbies, Katharina, Zimmermann, Hanna, Lorenz, Mario, Wernecke, Klaus-Dieter, Bellmann-Strobl, Judith, Paul, Friedemann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954462/
https://www.ncbi.nlm.nih.gov/pubmed/33622766
http://dx.doi.org/10.1212/NXI.0000000000000964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954462/
https://www.ncbi.nlm.nih.gov/pubmed/33622766
http://dx.doi.org/10.1212/NXI.0000000000000964

Ejemplares similares